Alanine infusion during hypoglycaemia partly supports cognitive performance in healthy human subjects

Diabetic Medicine

Volumn 21, Issue 5, 2004, Pages 440-446

  Evans, M L ^a,c   Hopkins, D ^a   Macdonald, I A ^b   Amiel, S A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Alanine; Brain metabolism; Cognitive function; Counter regulation; Hypoglycaemia

Indexed keywords

ALANINE; GLUCAGON; GLUCOSE; LACTIC ACID;

ADULT; ARTICLE; COGNITION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; HYPOGLYCEMIA; MALE; NORMAL HUMAN; SYMPTOMATOLOGY;

ADULT; ALANINE; BLOOD GLUCOSE; COGNITION DISORDERS; GLUCOSE CLAMP TECHNIQUE; HORMONES; HUMANS; HYPOGLYCEMIA; INSULIN; LACTIC ACID; MALE; NEUROPSYCHOLOGICAL TESTS;

EID: 2342519996     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01174.x     Document Type: Article

References (40)

1. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med 1993; 329: 977-986.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
3. Sokoloff L. Metabolism of the central nervous system in vivo. In: Field, J, Magoun, HW, Hall, VE, eds. Handbook of Physiology-Neurophysiology. Baltimore: Waverly Press, 1960; III: 1843-1864.
4. Knudsen GM, Paulson OB, Hertz MM. Kinetic analysis of the human blood-brain barrier transport of lactate and its influence by hypercapnia. J Cereb Blood Flow Metab 1991; 11: 581-586.
5. Alm A, Tornquist P. Lactate transport through the blood-retinal and the blood-brain barrier. Opthalm Res 1985; 17: 181-184.
6. Sanchez del Pino MM, Peterson DR, Hawkins RA. Neutral amino acid transport characterisation of isolated luminal and abluminal membranes of the blood-brain barrier. J Biol Chem 1995; 270: 14913-14918.
7. Pardridge WM, Mietus LJ. Palmitate and cholesterol transport through the blood-brain barrier. J Neurochem 1980; 34: 463-466.
8. Page MA, Williamson DH. Enzymes of ketone body utilisation in human brain. Lancet 1971; ii: 66-69.
9. Schmoll D, Fuhrmann E, Gebhardt R, Hamprecht B. Significant amounts of glycogen are synthesized from 3-carbon compounds in astroglial primary cultures from mice with participation of the mitochondrial phosphoenolpyruvate carboxykinase isoenzyme. Eur J Biochem 1995; 227: 308-315.
10. Amiel SA, Archibald HR, Chusney G, Williams AJK, Gale EAM. Ketone infusion lowers hormone responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. Clin Sci 1991; 81: 189-194.
11. Maran A, Cranston ICP, Lomas J, Macdonald L, Amiel SA. Protection by lactate of cerebral function during hypoglycaemia. Lancet 1994; 343: 16-20.
12. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes 1994; 43: 1311-1317.
13. King P, Parkin H, Macdonald IA, Barber C, Tattersall RB. The effect of intravenous lactate on cerebral function during hypoglycaemia. Diabet Med 1997; 14: 19-28.
14. King P, Kong MF, Parkin H, Macdonald IA, Barber C, Tattersall RB. Intravenous lactate prevents cerebral dysfunction during hypoglycaemia in insulin-dependent diabetes mellitus. Clin Sci 1998; 94: 157-163.
15. Evans M, Lomas J, Matyka K, Cranston I, MacDonald L, Amiel SA. Reduced counter-regulation during hypoglycaemia with raised circulating non-glucose lipid substrates: evidence for regional differences in metabolic capacity in the human brain. J Clin Endocr Metab 1998; 83: 2952-2959.
16. Bhattacharya SB, Datta AG. Is the brain a gluconeogenic organ? Mol Cell Biochem 1993; 125: 51-57.
17. Liu D, Moberg E, Kollind K, Lins P-E, Macdonald IA. Arterial, arterialized venous, venous and capillary blood glucose estimation in normal man during hyperinsulinaemic euglycaemia and hypoglycaemia. Diabetologia 1992; 35: 287-290.
18. Amiel SA, Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS. The rate of glucose fall does not affect the counter-regulatory hormone responses to hypoglycemia. Diabetes 1987; 36: 518-522.
19. Hepburn D. Symptoms of hypoglycaemia. In: Frier, BM, Fisher, BM, eds. Hypoglycaemia and Diabetes: Clinical and Physiological Aspects. London: Edward Arnold, 1993, 93-103.
20. Wilkinson RT, Houghton D. Portable four-choice reaction time test with magnetic tape memory. Behav Res Meth Instumentation 1975; 7: 441-446.
21. Stroop J. Studies of interference in serial verbal reaction. J Exp Psychol 1935; 18: 643-622.
22. Fromm-Auch D, Yeudall L. Normative data for the Halstead-Reitan tests. J Clin Neuropsychol 1983; 5: 221-238.
23. Heller S, Macdonald I. The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness. Diabet Med 1996; 13: 607-615.
24. Forster CD, Macdonald IA. The analysis of catecholamines in small volumes of human plasma. Biomed Chromatogr 1999; 13: 209-15.
25. Borg M, Sherwin RS, Borg W, Tamborlane WV, Shulman G. Local ventromedial hypothalamus perfusion blocks counter-regulation during systemic hypogrycemia in awake rats. J Clin Invest 1997; 99: 361-365.
26. Ritter S, Dinh TT. 2-Mercaptoacetate and 2-deoxy-D-glucose induce Fos-like immunoreactivity in rat brain. Brain Res 1994; 28: 110-120.
27. Kuhara T, Ikeda S, Ohneda A, Sasaki Y. Effects of intavenous infusion of 17 amino acids on the secretion of growth hormone, glucagon and insulin in sheep. Am J Physiol 1991; 206: E21-E26.
28. Wise JK, Henler R, Felig P. Evaluation of α-cell function by infusion of alanine in normal and diabetic subjects. New Engl J Med 1973; 288: 487-490.
29. Nair K, Welle SL, Tito J. Effect of plasma amino acid replacement on glucagon and substrate responses to insulin-induced hypoglycemia in humans. Diabetes 1990; 39: 376-382.
30. Saleh TY, Cryer PE. Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM. Diabetes Care 1997; 20: 1231-1236.
31. Rosenthal JM, Amiel SA, Yágüez L, Bullmore E, Hopkins D, Evans M, et al. The effect of acute hypoglycemia on brain function and activation - an fMRI study. Diabetes 2001; 50: 1618-1626.
32. Carter CS, Mintun M, Cohen JD. Intereference and facilitation effects during selective attention. an H215O PET study of Stroop task performance. Neuroimage 1995; 2: 264-272.
33. Magistretti PJ, Pellerin L. Metabolic coupling during activation: a cellular view. Adv Exp Med Biol 1997; 413: 161-166.
34. 13C magnetic resonance spectroscopy. J Neurosci Res 2001; 66: 737-746.
35. Soothill PW, Kouseibati F, Watts RL, Watts DC. Glycolytic, pentose phosphate shunt and transaminase enzymes in gastrocnemius muscle, liver, heart, and brain of 2 mouse mutants, 129 J-dy and A2g-adr with abnormal muscle function. J Neurochem 1981; 37: 506-510.
36. Cesar M, Hamprecht B. Immunochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase. J Neurochem 1995; 64: 2313-2318.
37. Tsacopoulos M, Magistrette PJ. Metabolic coupling between glia and neurons. J Neurosci 1996; 16: 877-885.
38. Felig P, Wahren J, Ahlborg G. Uptake of individual amino acids by the human brain. Proc Soc Exp Biol Med 1973; 142: 230-231.
39. Grill V, Bjorkmann O, Gutniak M, Lindqvist M. Brain uptake and release of amino acids in non-diabetic and insulin-dependent diabetic subjects: important role of glutamine release for nitrogen balance. Metabolism 1992; 41: 28-32.
40. Wahren J, Ekberg K, Fernqvist-Forbes E, Nair S. Brain substrate utilization during acute hypoglycaemia. Diabetologia 1999; 42: 812-818.